Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Patent
1996-03-25
1998-08-18
Patterson, Jr., Charles L.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
4353201, 435236, 514 44, 536 231, C12N 510, C07H 1910, C61K 3170
Patent
active
057957789
ABSTRACT:
An enzymatic RNA molecule which specifically cleaves a herpes simplex virus mRNA molecule.
REFERENCES:
Taylor, et al., "Ribozyme-Mediated Cleavage of an HIV-1 gag RNA: The Effects of Nontargeted Sequences and Secondary Structure on Ribozyme Cleavage Activity", 1 Antisense Res and Dev 173, 1991.
Sambrook, et al., "Molecular Cloning: A Laboratory Manual", published by Cold Spring Harbor Laboratory Press (N.Y.), pp. 7.71-7.78, 1989.
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silyated Ribonucleoside 3'-0-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichia coli Formylmethionine tRNA", 109 Jrnl of Amer. Chem. Society, 7845, 1987.
Slim et al., "Configurationally Defined Phosphorothioate-Containing Oligoribonucleotides in the Study of the Mechanism of Cleavage of Hammerhead Ribozymes", 19 Nucl. Acids Res. 1183, 1991.
Tsukiyama-Kohara et al., "Internal Ribosome Entry Site Within Hepatitis C Virus RNA", 66 Jrnl of Virol. 1476, 1992.
Zuker and Stiegler, 9 Nucleic Acids Research 133, 1981, "Optimal Computer Folding of Large RNA Sequences Using Thermodynamics and Auxiliary Information".
Jaeger et al., 86 Proc. Natl. Acad. Sci. USA 7706, 1989, "Improved Predictions of Secondary Structures for RNA".
Zuker, 244 Science 48, 1989, "On Finding All Suboptimal Foldings of an RNA Molecule".
Koizumi et al., 117 Gene 179, 1992, "Ribozymes Designed to Inhibit Transformation of NIH3T3 Cells by the Activated c=Ha-ras Gene".
Sioud and Drlica, 88 Proc. Natl. Acad. Sci. USA 7303, 1991, "Prevention of Human Immunodeficiency Virus Type 1 Integrase Expression in Escherichia coli by a Ribozyme".
Sarver et al., 247 Science 1222, 1990, "Ribozymes as Potential Anti-HIV-1 Therapeutic Agents".
Scanlon et al., 88 Proc. Natl. Acad. Sci. USA 10591, 1991, "Ribozyme-Mediated Cleavage of c-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein".
Chuat and Galibert, 162 Biochemical and Biophysical Research Communications 1025, 1989, "Can Ribozymes be Used to Regulate Procaryote Gene Expression?".
Dropulic et al., 66 Journal of Virology 1432, 1992, "Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus Type I Expression".
Sarver et al., 2 AIDS Res. Revs. 259, 1992, "Catalytic RNAs (Ribozymes): A New Frontier in Biomedical Applications".
Kashani-Sabet et al., 2 Antisense Research & Development 3, 1992, "Reversal of the Malignant Phenotype by an Anti-ras Ribozyme".
Chen et al., 20 Nucleic Acids Research 4581, 1992, "Multitarget-Ribozyme Directeed to Cleave at up to Nine Highly Conserved HIV-1 env RNA Regions Inhibits HIV-1 Replication-Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates".
Cameron and Jennings, 86 Proc. Natl. Acad. Sci. USA 9139, 1989, "Specific Gene Suppression by Engineered Ribozymes in Monkey Cells".
Weerasinghe et al., 65 Journal of Virology 5531, 1991, "Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4.sup.+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing an HIV-1 RNA-Specific Ribozyme".
Perrotta and Been, 31 Biochemistry 16, 1992, "Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis .delta. Virus RNA Sequence".
Hampel and Tritz, 28 Biochemistry 4929, 1989, "RNA Catalytic Properties of the Minimum (-)sTRSV Sequence".
Hampel et al., 18 Nucleic Acids Research 299, 1990, "`Hairpin` Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA".
Weerasinghe et al., 65 Journal of Virology 5531, 1991, "Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4.sup.+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing an HIV-1 RNA-Specific Ribozyme".
Mamone et al., "Design of Hammerhead Ribozymes Targeted to Sequences in HIV, HSV, and the Rat ANF Gene", Abstract of Keystone, CO (May 27, 1992).
Pavco et al., "Regulation of Self-Splicing Reactions by Antisense RNA", Abstract of Keystone, CO (May 27, 1992).
Haseloff and Gerlach, 334 Nature 585, 1988, "Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities".
Guerrier-Takada et al., 35 Cell 849, 1983, "The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme".
Hackh's Chemical Dictionary, 4th ed. (J. Grant, ed), p. 242 McGraw-Hill Book Company (1969).
New Riverside University Dictionary (1984), p. 437, Houghton Mitflin Co.
Rossi, J.J., et al. (1990) Trends Biotech, 8, 179-183.
Patterson Jr. Charles L.
Ribozyme Pharmaceuticals Inc.
LandOfFree
Method and reagent for inhibiting herpes simplex virus replicati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and reagent for inhibiting herpes simplex virus replicati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and reagent for inhibiting herpes simplex virus replicati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114049